hyperkeratosis

Hand Foot Skin Reaction Associated With Palbociclib
Palbociclib
by NEXT STEPS IN DERM TEAM on
INTRODUCTION Palbociclib is one of three new small-molecule inhibitors of cyclin-dependent kinase 4 and 6 (CDK4/6) approved for use in the treatment of hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (Her2-) advanced or metastatic breast cancer. CDK4/6 inhibitors have a good overall safety profile but reported side effects include cytopenias, diarrhea, QTc pr …
Alopecia in Skin of Color: Alternative Therapies
Alopecia in Skin of Color
by Cula N. Dautriche, MD, PhD on
Management of alopecia in skin of color is challenging due to a paucity of research into its pathophysiology coupled with a poor understanding of the basic hair care practices in this patient population. For the patient, it is often associated with severe emotional distress. Unfortunately, many forms of hair loss are refractory to standard therapies. At the 2020 Skin of Color Virtual Update, Dr …